{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:16:58Z","timestamp":1763036218325},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1097\/wno.0b013e3180334d27","type":"journal-article","created":{"date-parts":[[2007,3,30]],"date-time":"2007-03-30T09:10:37Z","timestamp":1175245837000},"page":"57-60","source":"Crossref","is-referenced-by-count":12,"title":["Rethinking Neuromyelitis Optica (Devic Disease)"],"prefix":"10.1097","volume":"27","author":[{"given":"Shelley Ann","family":"Cross","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-14-20210126","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0140-6736(03)12784-5","article-title":"Neuromyelitis optica: what it is and what it might be.","volume":"9361","author":"Weinshenker","year":"2003","journal-title":"Lancet"},{"key":"R2-14-20210126","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1212\/01.WNL.0000145762.60562.5D","article-title":"Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis.","volume":"63","author":"Cree","year":"2004","journal-title":"Neurology"},{"key":"R3-14-20210126","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devics syndrome).","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"R4-14-20210126","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/01.WNL.0000159399.81861.D5","article-title":"An open label study of the effects of rituximab in neuromyelitis optica.","volume":"64","author":"Cree","year":"2005","journal-title":"Neurology"},{"issue":"Suppl 1","key":"R5-14-20210126","first-page":"A519","article-title":"Identification of a marker autoantibody of neuromyelitis optica [abstract].","volume":"60","author":"Lennon","year":"2003","journal-title":"Neurology"},{"key":"R6-14-20210126","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"R7-14-20210126","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.","volume":"202","author":"Lennon","year":"2005","journal-title":"J Exp Med"},{"issue":"Suppl 2","key":"R8-14-20210126","first-page":"A183","article-title":"MRI brain lesions characteristic of neuromyelitis optica (NMO) colocalize with sites of high aquaporin protein concentrations [abstract].","volume":"66","author":"Pittock","year":"2006","journal-title":"Neurology"},{"key":"R9-14-20210126","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ncl.2004.09.002","article-title":"The pathology of multiple sclerosis.","volume":"23","author":"Lucchinetti","year":"2005","journal-title":"Neurol Clin"},{"key":"R10-14-20210126","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ana.20770","article-title":"Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis.","volume":"59","author":"Weinshenker","year":"2006","journal-title":"Ann Neurol"},{"key":"R11-14-20210126","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1212\/01.WNL.0000049912.02954.2C","article-title":"Neuromyelitis optica: clinical predictors of a relapsing course and survival.","volume":"60","author":"Wingerchuk","year":"2003","journal-title":"Neurology"},{"key":"R13-14-20210126","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1212\/01.WNL.0000154673.37555.6F","article-title":"Western vs optic-spinal MS: two diseases, one treatment?","volume":"64","author":"Weinshenker","year":"2005","journal-title":"Neurology"},{"key":"R14-14-20210126","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1474-4422(06)70333-7","article-title":"OSMS is NMO, but not MS: proven clinically and pathologically.","volume":"5","author":"Weinshenker","year":"2006","journal-title":"Lancet Neurol"},{"key":"R15-14-20210126","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1212\/WNL.62.1.144","article-title":"Absence of IgG1 response in the cerebrospinal fluid of relapsing neuromyelitis optica.","volume":"62","author":"Nakashima","year":"2004","journal-title":"Neurology"},{"issue":"Suppl 2","key":"R16-14-20210126","first-page":"A307","article-title":"The prevalence of non-organ-specific autoantibodies and NMO-IgG in neuromyelitis optica (NMO) and related disorders [abstract].","volume":"66","author":"Pittock","year":"2006","journal-title":"Neurology"},{"issue":"Suppl 2","key":"R17-14-20210126","first-page":"A380","article-title":"The relationship between neuromyelitis optica and systemic autoimmune disease [abstract].","volume":"66","author":"Weinshenker","year":"2006","journal-title":"Neurology"},{"key":"R18-14-20210126","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1212\/01.WNL.0000106946.08741.41","article-title":"Magnetization transfer and diffusion tensor MRI show gray matter damage in neuromyelitis optica.","volume":"62","author":"Rocca","year":"2004","journal-title":"Neurology"},{"key":"R19-14-20210126","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/archneur.63.3.390","article-title":"Brain abnormalities in neuromyelitis optica.","volume":"63","author":"Pittock","year":"2006","journal-title":"Arch Neurol"},{"issue":"Suppl 1","key":"R20-14-20210126","first-page":"A38","article-title":"Neuromyelitis optica diagnostic criteria revisited: validation and incorporation of the NMO-IgG serum autoantibody [abstract].","volume":"64","author":"Wingerchuk","year":"2005","journal-title":"Neurology"},{"key":"R21-14-20210126","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica.","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"}],"container-title":["Journal of Neuro-Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNO.0b013e3180334d27","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:35:20Z","timestamp":1620977720000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00041327-200703000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/wno.0b013e3180334d27","relation":{},"ISSN":["1070-8022"],"issn-type":[{"value":"1070-8022","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}